Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Cascadian Therapeutics Inc. (CASC)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1. 0 $0 0%
2. 0 $0 0%
3. 0 $0 0%
4. 0 $0 0%
5.
Sabby Capital

Hal Mintz

0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaning Holdings Date Form 4
$3.93 1,000 Officer, Director 39,416 2017-03-20 Filing
$4.24 23,000 Director 27,209 2017-02-02 Filing
$4.11 25,324 Director 50,000 2017-01-30 Filing
$3.76 20,500 Officer, Director 38,416 2017-01-27 Filing
$1.15 45,000 Officer, Director 107,500 2016-08-17 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$1.72 3,403 Director 20,644 2013-07-10 Filing
$1.96 12,780 Director 24,047 2013-02-20 Filing
$8.74 28,900 Large Shareholder 2,985,238 2011-06-23 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 1,015,607 $1,290 1.35%
2. 311,550 $396 0.49%
3. 408,200 $37 0.03%
4. 20,279 $26 0%
5. 200 $1 0%
News See All